Immunovant Inc [IMVT] Shares Fall Approximately -36.30% Over the Year
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunovant Inc’s recently made public that its Director Pande Atul unloaded Company’s shares for reported $0.22 million on Dec 02
Immunovant Inc’s recent filing unveils that its Director Pande Atul unloaded Company’s shares for reported $0.22 million on Dec 02
Immunovant Inc’s recent filing unveils that its Officer DOUGLAS J. HUGHES acquired Company’s shares for reported $0.15 million on Dec
In a filing, Immunovant Inc revealed its Chief Legal Officer Levine Mark S. unloaded Company’s shares for reported $92892.0 on
In a filing, Immunovant Inc revealed its Chief Legal Officer Levine Mark S. unloaded Company’s shares for reported $0.13 million
In a filing, Immunovant Inc revealed its Chief Legal Officer Levine Mark S. unloaded Company’s shares for reported $0.13 million
Immunovant Inc’s filing revealed that its Chief Legal Officer Levine Mark S. unloaded Company’s shares for reported $0.13 million on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Immunovant Inc
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Immunovant Inc
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.